Sit Investment Associates’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$85K Sell
235
-175
-43% -$59.9K ﹤0.01% 479
2026
Q1
$144K Hold
410
﹤0.01% 448
2025
Q4
$134K Hold
410
﹤0.01% 461
2025
Q3
$116K Hold
410
﹤0.01% 467
2025
Q2
$114K Hold
410
﹤0.01% 476
2025
Q1
$128K Sell
410
-50
-11% -$14.8K ﹤0.01% 470
2024
Q4
$120K Hold
460
﹤0.01% 479
2024
Q3
$148K Sell
460
-290
-39% -$94.9K ﹤0.01% 481
2024
Q2
$234K Sell
750
-325
-30% -$95.5K 0.01% 451
2024
Q1
$306K Buy
1,075
+115
+12% +$33.6K 0.01% 433
2023
Q4
$276K Sell
960
-50
-5% -$13.6K 0.01% 447
2023
Q3
$271K Hold
1,010
0.01% 438
2023
Q2
$224K Sell
1,010
-75
-7% -$17.4K 0.01% 466
2023
Q1
$262K Buy
1,085
+215
+25% +$52.8K 0.01% 451
2022
Q4
$228K Buy
+870
New +$233K 0.01% 455
2020
Q4
Sell
-22,945
Closed -$5.83M 522
2020
Q3
$5.83M Sell
22,945
-15,305
-40% -$3.79M 0.17% 174
2020
Q2
$9.02M Sell
38,250
-1,100
-3% -$251K 0.28% 111
2020
Q1
$7.98M Buy
39,350
+6,550
+20% +$1.43M 0.3% 101
2019
Q4
$7.91M Buy
32,800
+400
+1% +$88.2K 0.22% 138
2019
Q3
$6.27M Sell
32,400
-8,385
-21% -$1.61M 0.19% 155
2019
Q2
$7.52M Sell
40,785
-18,850
-32% -$3.38M 0.23% 133
2019
Q1
$11.3M Sell
59,635
-20,530
-26% -$3.92M 0.36% 89
2018
Q4
$15.6M Sell
80,165
-18,710
-19% -$3.65M 0.5% 58
2018
Q3
$20.5M Buy
98,875
+28,284
+40% +$5.57M 0.53% 60
2018
Q2
$13M Buy
+70,591
New +$12.5M 0.34% 99

Other funds holding AMGN

Sit Investment Associates's AMGN Position: Q2 2026 in Review

Sit Investment Associates reduced its Amgen (AMGN) stake by 43% in Q2 2026, selling an estimated $59.9K and leaving 235 shares worth $85K. The position accounts for ﹤0.01% of the portfolio, ranked #479.

Sit Investment Associates first reported a position in AMGN in Q2 2018 and has held it in 25 quarters since. The position peaked at $20.5M in Q3 2018. 3,156 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Sit Investment Associates held 235 shares of Amgen worth $85K as of Q2 2026.
  • Sit Investment Associates sold 175 Amgen shares in Q2 2026, an estimated $59.9K.
  • Amgen made up ﹤0.01% of Sit Investment Associates's portfolio in Q2 2026, its #479 holding.
  • Sit Investment Associates first reported a position in Amgen in Q2 2018 and has held it in 25 quarters since.
  • Sit Investment Associates's Amgen position peaked at $20.5M in Q3 2018.
  • 3,156 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Sit Investment Associates's 13F filing for Q2 2026, filed 12 Aug 2026.